top of page
Pregnant Belly_edited.jpg
inga_logo_black.png

MAKING LABOR INDUCTION SAFER, MORE ACCESSIBLE, AND DATA-DRIVEN

A call for urgent global action to develop improved, safety-enhancing quantitative monitoring solutions for labor induction, particularly those suitable for at-home and outpatient settings.

Maternity Innovations Needed

Induction is a commonly employed procedure in modern labor and delivery practices; however, induction continues to be a high-risk procedure for both mother and baby, particularly for women of color.​

​

​​Labor induction is challenging for over 10 million women in rural areas who lack timely access to proper obstetric care. Poor outcomes often result from maternal or fetal risk factors, suboptimal management of the induction process, and additional challenges like obesity and ethnicity, which complicate monitoring. This leads to higher risks and poorer care, especially for women of color and those in underserved regions. There is a critical need for advanced, quantitative monitoring devices that can be used in outpatient settings to enhance access and improve labor and delivery outcomes for these populations.

​

​We aim to address the critical challenges faced in labor induction, especially for women in rural areas who face limited access to obstetric care. We think that better quality birth healthcare needs to be safer and accessible for every woman, regardless of their shape, size, or color.​

Ob-Gyn and Engineering Collaboration

We're dedicated to rethink maternal-fetal health through innovation: setting women safely in motion with affordable high-quality maternal and fetal well-being measuring remote monitoring device which is designed to transform the labor induction safer, healthier and more engaging experience.

Our solution, a data-driven monitoring platform for safer labor induction, is the result of seamless collaboration between a diverse team of experts. We've developed a groundbreaking non-invasive sensor system to be used as part of the current standard of care, specifically with Foley catheter cervical ripening. This sensor technology significantly enhances outpatient safety, reduces healthcare costs, and ultimately improves the birthing experience for millions of women worldwide.

- Designed for healthcare to safely mobilize mothers.

Novel sensor technology

Large international studies have shown that at-home, outpatient induction is a safe and effective option for birthing women.

​

Our aim is to set women safely in motion, out of the birthing room and off one hospital floor, and to enhance the safe labor induction through optimized, efficient, and personalized labor induction management. Our smart technology enables healthcare providers to monitor mothers' contractions and fetal heart rate during Foley catheter cervical ripening, whether in inpatient or outpatient settings.

 

For healthcare providers, this technology serves as a remote data-driven decision-making tool for timely and informed induction process management, leading to improved fetal and maternal safety. Continuous real-time monitoring of induction progress enables anticipation of treatment needs and promotes more efficient use of hospital resources, ultimately saving healthcare resources.

​

Our system enhances patient safety, mobility, and provides them with valuable insights into their personal birth journey. By keeping mothers informed, it helps reduce stress and anxiety, leading to a better childbirth experience. The design of our sensor system prioritizes comfort throughout the labor induction journey.

​

We have patent pending solution. Currently, we are conducting initial clinical validations for our sensor technology at Finland-based Helsinki University Hospital. 

Business Finland logo
Aalto university logo
Helsinki University Hospital HUS logo
Biodesign logo.png
 Spark Finland logo
Aalto university startup center pre-business R2B
Päivikki and Sakari Sohlberg foundation logo

RECENT NEWS

01

30   /   11   /   2022

New labor induction research studies published.

02

01   /   05   /   2024

Received €474k additional funding from the Jane and Aatos Erkko Foundation.

03

27   /   09   /   2023

The Inga project started initial clinical validation at Finland-based Helsinki University Hospital (HUS).

04

30   /   04   /   2023

The Inga project was granted Research to Business (R2B) funding from Business Finland.

05

01   /   01   /   2023

The Inga project was selected as one of the promising projects for Spark Finland's three-year mentoring program for Batch Spring 2023.

06

30   /   11   /   2022

The "INGA" research group was established in Finland-based Aalto University. Get to know us and learn about the research background of Inga.

Did Inga pique your interest?

Join our email list and be the first to hear our latest research news

Thanks for submitting!

bottom of page